Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
MMEDIPAL HOLDINGS CORPORATION logo
7459TSE Prime

MEDIPAL HOLDINGS CORPORATION

メディパルホールディングス Yahoo Finance

Recent & upcoming events

Aug 5
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 23
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
May 14
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 28
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
2027
Jan 20
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 14
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jun 30
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥3.82T YoY +4.0%
Operating income ¥53.18B margin 1.4%
Net income ¥42.53B YoY +5.6%
EPS ¥207 YoY +7.0%
P/E —
ROE 6.7% Equity ratio 34% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥3.94T +3.3%
Operating income ¥53.50B +0.6%
Net income ¥43.00B +1.1%
EPS ¥210 +1.6%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q2
Revenue ¥886.74B¥892.25B¥935.93B¥843.82B——
Operating income ¥12.40B¥8.23B¥16.58B¥10.12B——
Net income ¥13.95B¥8.59B¥14.20B¥15.03B——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

国内機関 19%海外機関 11%アクティビスト 5%未開示 60.8%202120222023202420252026
事業法人国内機関海外機関アクティビスト個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

日本マスタートラスト信託銀行株式会社 14.7%日本マスタートラスト信託銀行株式会社（信託口）株式会社日本カストディ銀行（信託口） 4.2%株式会社日本カストディ銀行（信託口）ＳＴＡＴＥ　ＳＴＲＥＥＴ　ＢＡＮＫ　 2.9%ＳＴＡＴＥ　ＳＴＲＥＥＴ　ＢＡＮＫ　ＡＮＤ　ＴＲＵＳＴ　ＣＯＭＰＡＮＹ　５０５００１（常任代理人　株式会社みずほ銀行決済営業部）小林製薬株式会社 2.5%小林製薬株式会社MＰグループメディセオ従業員持株会 1.9%MＰグループメディセオ従業員持株会ＪＰ ＭＯＲＧＡＮ ＣＨＡＳＥ ＢＡ 1.5%ＪＰ ＭＯＲＧＡＮ ＣＨＡＳＥ ＢＡＮＫ ３８０６８４（常任代理人 株式会社みずほ銀行決済営業部）202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
日本マスタートラスト信託銀行株式会社（信託口） 30,142,000 14.7% Yuho (EDINET)
NORTHERN TRUST CO． （AVFC） RE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE EQUITY TRUST 10,130,000 5.0% Yuho (EDINET)
株式会社日本カストディ銀行（信託口） 8,665,000 4.2% Yuho (EDINET)
STATE STREET BANK AND TRUST COMPANY 505001 5,834,000 2.9% Yuho (EDINET)
NORTHERN TRUST CO．（AVFC） RE U．S． TAX EXEMPTED PENSION FUNDS 5,793,000 2.8% Yuho (EDINET)
小林製薬株式会社 5,074,000 2.5% Yuho (EDINET)
NORTHERN TRUST CO．（AVFC） RE NON TREATY CLIENTS ACCOUNT 4,310,000 2.1% Yuho (EDINET)
MPグループメディセオ従業員持株会 3,778,000 1.9% Yuho (EDINET)
NORTHERN TRUST CO．（AVFC） RE IEDU UCITS CLIENTS NON LENDING 15 PCT TREATY ACCOUNT 3,458,000 1.7% Yuho (EDINET)
JP MORGAN CHASE BANK 380684 3,133,000 1.5% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

6/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 2.2%
✓ Positive operating cash flow ¥46.55B
✓ ROA improved YoY 2.2% → 2.2%
✓ Operating CF exceeds net income (accrual quality) OCF ¥46.55B / net income ¥42.53B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 33.9% → 33.9%
✓ Current ratio improved 1.27× → 1.28×
✓ No dilution (shares outstanding did not increase) 219,226,000 → 215,975,000
✗ Gross margin improved 7.0% → 6.8%
✗ Asset turnover improved 2.01× → 1.99×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 33.9%
Current ratio 1.3×
Years of positive operating CF 10 of last 10 yrs
Payout ratio 85%
Latest fiscal year result Profit (net income ¥42.53B)

Performance history

Last 10 years
0.0兆円1.0兆円1.9兆円2.9兆円3.8兆円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 30,63931,46331,81932,53132,11132,90933,60035,58736,71338,174
Operating income 397443498531386456490473556532
Ordinary income 534573639680530620651646653757
Net income 290348344380239294388415403425
Total assets 15,25916,21616,17916,44316,79917,09517,03917,99118,25019,220
Equity 5,2125,7275,9286,0746,3896,4916,8817,3667,5797,954

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥128¥154¥154¥176¥114¥140¥185¥196¥193¥207
ROE 6.8%7.5%7.0%7.6%4.7%5.6%7.1%7.1%6.6%6.7%
Operating CF 480636637569344612161618606466
Investing CF -114-431-235-133-29.4-243-395-78.2-33.693.0
Financing CF -177158-308-491-160-165-435-252-259-294
FCF 366205402436315369-233540572559

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data